Loading clinical trials...
Loading clinical trials...
Metabolic Surgery for Type 2 Diabetes
Surgical treatment for type 2 diabetes has been taken note especially in less obese or non obese patients. In Asian, the nuber of less obses or non obese patients with T2DM is greater than that of the obese. We are trying to do a prospective observational study for the evaluation of the effect of duidenojejunal bypass and gastric bypass on the glycemoc control in those patients. The selection criteria are type 2 diabetess, 20-60 years old, BMI 23-34 or 21-22 with viceral obesity, insulin use less than 10 years and the patients understanding the hypothesis of this study, risks, expecting effects and agreeing this study. We are checking oral GTT, insulin level, C-peptide level, HbA1C, etc. with some anthropometric measurs preoperatively, postoperatively, at 3 month and 12 month. We will compare the clinical factors at each time.
Age
20 - 65 years
Sex
ALL
Healthy Volunteers
No
Yoonseok Heo
Incheon, South Korea
Start Date
December 1, 2009
Primary Completion Date
December 1, 2011
Completion Date
October 1, 2012
Last Updated
November 28, 2012
20
ACTUAL participants
laparoscopic roux en Y gastric bypass / open duodenojejunal bypass
PROCEDURE
Lead Sponsor
Inha University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions